Intangible Asset, Net - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 25, 2024 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Nov. 18, 2025 |
Nov. 18, 2015 |
|
| Intangible Assets Net Excluding Goodwill [Line Items] | |||||
| Amortization of intangible asset | $ 342 | $ 0 | |||
| Pfizer License Agreement | |||||
| Intangible Assets Net Excluding Goodwill [Line Items] | |||||
| Regulatory milestone payments upon approval of product | $ 20,000 | $ 20,000 | |||
| Regulatory milestone payment amortization period | 14 years 4 months 24 days | ||||
| X | ||||||||||
- Definition Intangible assets net excluding goodwill. No definition available.
|
| X | ||||||||||
- Definition Regulatory milestone payment amortization period. No definition available.
|
| X | ||||||||||
- Definition Regulatory milestone payments upon approval of product. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|